Control-IQ technology uses sensor values from your continuous glucose monitor (CGM) to predict glucose values 30 minutes in the future and adjust insulin delivery accordingly. Control-IQ technology aims to increase the time spent in range between 70-180 mg/dL.
Control-IQ technology will decrease or stop basal insulin delivery when glucose levels are predicted to fall below the treatment range.
Control-IQ technology will increase basal insulin delivery and can deliver an automatic correction bolus when glucose levels are predicted to rise above the treatment range. An automatic correction bolus delivers 60% of calculated dose up to once an hour if glucose is predicted to be greater than or equal to 180 mg/dL. Please see the graphic below for more information. The treatment values may be different if a sleep or exercise activity is enabled.
Always refer to the User Guide for important safety information and detailed step-by-step instructions on how Control-IQ technology works. Please consult the applicable user guide and refer to the table of contents.